Topcon
7732
TEMONA
3985
Forside
2330
Okamoto Glass
7746
Delta-Fly Pharma
4598
(FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | (FY)Dec 31, 2017 | (FY)Dec 31, 2016 | (FY)Dec 31, 2015 | (FY)Dec 31, 2014 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | -10.12%6.99B | 22.04%7.78B | 28.81%6.37B | 102.62%4.95B | -44.37%2.44B | 18.65%4.39B | -49.74%3.7B | -24.32%7.36B | 587.50%9.72B | 1.41B |
Net profit before non-cash adjustment | 5.47%6.89B | 9.07%6.54B | 73.98%5.99B | 36.20%3.45B | -19.30%2.53B | -6.13%3.13B | -18.64%3.34B | 5.98%4.1B | 29.56%3.87B | --2.99B |
Total adjustment of non-cash items | -85.60%141.85M | 5.47%985.06M | -23.55%933.97M | 111.83%1.22B | -52.75%576.74M | 41.52%1.22B | -29.15%862.46M | -25.08%1.22B | 32.08%1.62B | --1.23B |
-Depreciation and amortization | -10.58%786.35M | -2.15%879.42M | 11.07%898.75M | 22.50%809.15M | -39.45%660.53M | -25.12%1.09B | 4.04%1.46B | 3.70%1.4B | -5.67%1.35B | --1.43B |
-Reversal of impairment losses recognized in profit and loss | --0 | 42.59%75.15M | -11.41%52.7M | --59.49M | ---- | ---- | ---- | ---- | ---- | ---- |
-Assets reserve and write-off | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -65.34%80.89M | --233.36M |
-Share of associates | 181.47%3.4M | 29.21%-4.17M | 54.93%-5.89M | 51.27%-13.07M | 59.93%-26.83M | -22.41%-66.96M | 5.95%-54.7M | -168.15%-58.16M | --85.34M | ---- |
-Disposal profit | -719.93%-138.5M | 123.26%22.34M | -169.68%-96.06M | 55.85%137.85M | -46.26%88.45M | 364.56%164.59M | -617.79%-62.21M | 11.64%12.02M | -83.63%10.76M | --65.74M |
-Pension and employee benefit expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 277.49%402.01M | --106.49M |
-Other non-cash items | -4,236.03%-509.39M | -85.42%12.32M | -63.00%84.47M | 256.98%228.29M | -553.19%-145.42M | 106.72%32.09M | -248.89%-477.34M | 55.06%-136.82M | 49.83%-304.44M | ---606.83M |
Changes in working capital | -119.37%-48.88M | 145.29%252.31M | -299.62%-557.11M | 141.95%279.09M | -2,122.54%-665.23M | 106.54%32.89M | -124.70%-503.25M | -51.78%2.04B | 250.68%4.23B | ---2.8B |
-Change in receivables | -312.66%-417.74M | 487.84%196.43M | 78.21%-50.65M | 87.44%-232.44M | -269.46%-1.85B | 551.06%1.09B | -190.26%-242.02M | -439.58%-83.38M | -36,892.86%-15.45M | --42K |
-Change in inventory | 17.76%-353.02M | -23.98%-429.27M | -29.37%-346.23M | -26.81%-267.63M | -890.19%-211.05M | --26.71M | ---- | ---- | ---- | ---- |
-Change in payables | 8.35%550.24M | 232.67%507.82M | -145.65%-382.77M | -37.85%838.45M | 210.00%1.35B | -215.01%-1.23B | -311.04%-389.33M | 229.99%184.48M | 0.48%-141.92M | ---142.6M |
-Provision for loans, leases and other losses | 856.64%171.63M | -110.19%-22.68M | 475.28%222.53M | -227.22%-59.3M | -66.93%46.61M | 10.03%140.96M | 559.77%128.11M | ---27.86M | ---- | ---- |
-Changes in other current assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -100.24%-16.19M | 207.43%6.62B | ---6.17B |
-Changes in other current liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 188.40%1.98B | -163.95%-2.24B | --3.5B |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | 55.92%-134K | 94.56%-304K | -327.89%-5.58M | 38.03%-1.31M | 38.35%-2.11M | -28.66%-3.42M | 94.25%-2.66M | 37.45%-46.17M | 16.70%-73.82M | -88.62M |
Interest received (cash flow from operating activities) | 13.28%67.53M | 14.78%59.61M | -10.00%51.94M | -25.50%57.71M | 10.73%77.46M | -14.22%69.95M | 23.08%81.55M | 4.50%66.25M | 39.83%63.4M | 45.34M |
Tax refund paid | 41.45%-1.94B | -52.72%-3.31B | -145.44%-2.17B | 18.98%-883.36M | 32.11%-1.09B | 4.95%-1.61B | -5.10%-1.69B | 3.28%-1.61B | -5.41%-1.66B | -1.58B |
Other operating cash inflow (outflow) | -1K | 0 | -1K | 0 | 1K | 0 | 1K | 0 | 0 | 1K |
Operating cash flow | 13.12%5.12B | 6.45%4.52B | 3.16%4.25B | 188.82%4.12B | -49.93%1.43B | 36.45%2.85B | -63.83%2.09B | -28.31%5.77B | 4,015.28%8.05B | ---205.63M |
Investing cash flow | ||||||||||
Net PPE purchase and sale | 15.16%-314.45M | -19.59%-370.62M | -52.02%-309.9M | -70.60%-203.85M | 40.77%-119.49M | -80.37%-201.75M | -191.41%-111.86M | 66.91%-38.38M | 23.08%-116.01M | ---150.82M |
Net intangibles purchase and sale | -33.29%-471.73M | -25.08%-353.9M | 24.77%-282.94M | 31.37%-376.1M | 29.79%-548.04M | -28.87%-780.57M | -1.24%-605.7M | -92.18%-598.31M | -135.67%-311.32M | ---132.1M |
Net business purchase and sale | 111.37%27.97M | -96.71%13.23M | 444.74%402.05M | ---116.62M | ---- | ---- | 36.75%-89.73M | ---141.87M | ---- | ---- |
Net investment product transactions | -56.28%409.03M | 63.75%935.57M | 4,291.50%571.34M | 98.57%-13.63M | -9,464.96%-950.08M | -22.14%10.15M | 686.84%13.03M | 100.58%1.66M | -1,794.52%-283.19M | --16.71M |
Advance cash and loans provided to other parties | ---- | ---- | ---- | 99.96%-500K | -577.82%-1.12B | -168.97%-165.5M | ---61.53M | ---- | ---114.85M | ---- |
Repayment of advance payments to other parties and cash income from loans | ---- | ---- | ---- | 676.00%1.07B | --137.96M | ---- | ---- | ---- | --93.36M | ---- |
Net changes in other investments | -102.62%-79.28M | -566.69%-39.13M | -95.58%8.38M | 15,304.46%189.78M | 101.20%1.23M | -259.05%-102.28M | 109.20%64.3M | -179.22%-698.95M | 204.24%882.33M | --290.01M |
Investing cash flow | -331.40%-428.45M | -52.39%185.16M | -29.24%388.93M | 121.14%549.68M | -109.70%-2.6B | -56.66%-1.24B | 46.37%-791.48M | -1,081.82%-1.48B | 531.46%150.32M | --23.81M |
Financing cash flow | ||||||||||
Net issuance payments of debt | ---- | ---- | ---- | ---2.08B | ---- | ---- | 10.20%-1.4B | 7.40%-1.56B | -202.00%-1.68B | ---557.48M |
Net common stock issuance | -19.74%-3.75B | -20,996.65%-3.13B | -5.63%15M | -55.44%15.89M | -53.75%35.67M | -97.55%77.11M | 3,956.29%3.15B | 105.53%77.58M | ---1.4B | ---- |
Increase or decrease of lease financing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---64.73M | ---- | ---- |
Cash dividends paid | 0.01%-1.22B | -46.59%-1.22B | -30.75%-835.68M | 11.19%-639.16M | -0.70%-719.73M | -103.74%-714.69M | ---350.79M | ---- | ---- | ---- |
Net other fund-raising expenses | -85.88%-125.22M | -1,321.54%-67.37M | 97.21%-4.74M | -132.00%-170.01M | 76.39%-73.28M | -40.04%-310.33M | ---221.6M | ---- | 10.08%-91.08M | ---101.29M |
Financing cash flow | -15.28%-5.1B | -436.27%-4.43B | 71.28%-825.42M | -279.44%-2.87B | 20.10%-757.35M | -180.72%-947.91M | 175.95%1.17B | 51.36%-1.55B | -382.52%-3.18B | ---658.76M |
Net cash flow | ||||||||||
Beginning cash position | 1.92%19.94B | 24.10%19.57B | 14.57%15.77B | -11.95%13.76B | 4.72%15.63B | 19.78%14.93B | 28.93%12.46B | 117.09%9.66B | -15.77%4.45B | --5.29B |
Current changes in cash | -247.16%-414.92M | -92.61%281.94M | 112.39%3.81B | 192.95%1.8B | -392.33%-1.93B | -73.26%660.68M | -10.14%2.47B | -45.26%2.75B | 697.51%5.02B | ---840.59M |
Effect of exchange rate changes | -50.46%46.37M | 810.03%93.6M | -121.11%-13.18M | 545.13%62.43M | -64.20%-14.03M | -50.76%-8.54M | -128.19%-5.67M | 42,659.57%20.1M | -99.32%47K | --6.87M |
Cash adjustments other than cash changes | 0.00%1K | --1K | ---- | 90.40%147.18M | 49.09%77.3M | 5,184,500.00%51.85M | -100.00%1K | -86.02%26.58M | 19,012,700.00%190.13M | ---1K |
End cash Position | -1.85%19.57B | 1.92%19.94B | 24.10%19.57B | 14.57%15.77B | -11.95%13.76B | 4.72%15.63B | 19.78%14.93B | 28.93%12.46B | 117.09%9.66B | --4.45B |
Free cash flow | 14.17%4.33B | 4.40%3.79B | 2.85%3.63B | 365.62%3.53B | -59.35%758.67M | 36.21%1.87B | -73.32%1.37B | -32.65%5.13B | 1,660.45%7.62B | ---488.55M |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |